PMID- 32052065 OWN - NLM STAT- MEDLINE DCOM- 20200402 LR - 20200402 IS - 1618-2650 (Electronic) IS - 1618-2642 (Print) IS - 1618-2642 (Linking) VI - 412 IP - 8 DP - 2020 Mar TI - A quantum dot-based lateral flow immunoassay for the rapid, quantitative, and sensitive detection of specific IgE for mite allergens in sera from patients with allergic rhinitis. PG - 1785-1794 LID - 10.1007/s00216-020-02422-0 [doi] AB - The prevalence of allergic rhinitis (AR) is increasing worldwide. However, the current systems used to measure levels of immunoglobulin E (IgE) in sera are associated with several disadvantages that limit their further application. Consequently, there is a need to develop novel highly sensitive strategies that can rapidly detect IgE in a quantitative manner. The development of such systems will significantly enhance our ability to diagnose, treat, and even prevent AR. Herein, we describe our experience of using quantum dot-based lateral flow immunoassay (QD-LFIA), combined with a portable fluorescence immunoassay chip detector (PFICD), to detect serum-specific IgE against Dermatophagoides pteronyssinus (Der-p) and Dermatophagoides farinae (Der-f), two common mite allergens in China. Our data showed that our system could detect serum-specific levels of IgE against Der-p and Der-f as low as 0.093 IU/mL and 0.087 IU/mL, respectively. We also established a standard curve to determine serum-specific IgE concentrations that correlated well with the clinical BioIC microfluidics system. The sensitivity of our assay was 96.7% for Der-p and 95.5% for Der-f, while the specificity was 87.2% for Der-p and 85.3% for Der-f. Collectively, our results demonstrate that QD-LFIA is a reliable system that could be applied to detect serum-specific IgE in accordance with clinical demands. This QD-LFIA strategy can be applied at home, in hospitals, and in pharmacies, with reduced costs and time requirements when compared with existing techniques. In the future, this system could be developed to detect other types of allergens and in different types of samples (for example, whole blood). Graphical abstract We describe our experiment using a quantum dot-based lateral flow immunoassay combined with a portable fluorescence immunoassay chip detector for both qualitative and quantitative detection of serum-specific IgE against two common mite allergens. This strategy can be applied at home, in hospitals, and in pharmacies, with reduced costs and time requirements. In the future, this system could be developed to detect other types of allergens and in different types of samples. FAU - Liang, Zheng-Yan AU - Liang ZY AD - Department of Otolaryngology-Head and Neck Surgery, Central Laboratory, Renmin Hospital of Wuhan University, 238 Jie-Fang Road, Wuhan, 430060, Hubei, China. FAU - Deng, Yu-Qin AU - Deng YQ AD - Department of Otolaryngology-Head and Neck Surgery, Central Laboratory, Renmin Hospital of Wuhan University, 238 Jie-Fang Road, Wuhan, 430060, Hubei, China. FAU - Tao, Ze-Zhang AU - Tao ZZ AD - Department of Otolaryngology-Head and Neck Surgery, Central Laboratory, Renmin Hospital of Wuhan University, 238 Jie-Fang Road, Wuhan, 430060, Hubei, China. taozezhang11@163.com. AD - Institute of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, 238 Jie-Fang Road, Wuhan, 430060, Hubei, China. taozezhang11@163.com. LA - eng GR - NO.81670910/National Natural Science Foundation of China/ PT - Journal Article DEP - 20200212 PL - Germany TA - Anal Bioanal Chem JT - Analytical and bioanalytical chemistry JID - 101134327 RN - 0 (Allergens) RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Allergens/*blood MH - Humans MH - Immunoassay/*methods MH - Immunoglobulin E/*blood MH - Limit of Detection MH - Point-of-Care Systems MH - *Quantum Dots MH - Rhinitis, Allergic/*blood/immunology PMC - PMC7048869 OTO - NOTNLM OT - Allergic rhinitis OT - Immunoglobulin E OT - Lateral flow immunoassay OT - Quantum dots COIS- The authors declare that they have no competing conflicts of interest. EDAT- 2020/02/14 06:00 MHDA- 2020/04/03 06:00 PMCR- 2020/02/12 CRDT- 2020/02/14 06:00 PHST- 2019/11/11 00:00 [received] PHST- 2020/01/14 00:00 [accepted] PHST- 2020/01/08 00:00 [revised] PHST- 2020/02/14 06:00 [pubmed] PHST- 2020/04/03 06:00 [medline] PHST- 2020/02/14 06:00 [entrez] PHST- 2020/02/12 00:00 [pmc-release] AID - 10.1007/s00216-020-02422-0 [pii] AID - 2422 [pii] AID - 10.1007/s00216-020-02422-0 [doi] PST - ppublish SO - Anal Bioanal Chem. 2020 Mar;412(8):1785-1794. doi: 10.1007/s00216-020-02422-0. Epub 2020 Feb 12.